Myriad Genetics Adds Folate Receptor Alpha to Precise™ Oncology Solutions Portfolio to Expand Treatment Options for Women Living with Ovarian Cancer

Source: Nasdaq GlobeNewswire / 24 May 2023 15:05:00   America/Chicago